Proposed Registration Decision PRD2021-02, Picarbutrazox and VAYANTIS Seed Treatment
This summary describes the key points of the evaluation, while the Science Evaluation of Proposed Registration Decision PRD2021-02, Picarbutrazox and VAYANTIS Seed Treatment provides detailed technical information on the human health, environmental and value assessments of picarbutrazox and VAYANTIS Seed Treatment.
- Publisher - Current Organization Name: Health Canada
- Licence: Open Government Licence - Canada
Data and Resources
-
Proposed Registration Decision PRD2021-02, Picarbutrazox and VAYANTIS Seed TreatmentHTMLEnglish publication HTML
-
Proposed Registration Decision PRD2021-02, Picarbutrazox and VAYANTIS Seed TreatmentHTMLFrench publication HTML
Similar records